ASTC.NASDAQAstrotech CORP

10-Q: Astrotech Corporation Reports Q2 2025 Results: Revenue Declines, R&D Spending Increases

Sentiment:

Quarterly Report (Form 10-Q)


Astrotech Corporation's Q2 2025 revenue decreased compared to Q2 2024, while research and development expenses increased significantly.

Worse than expectedRevenue decreased significantly compared to the same period last year.Net losses increased compared to the same period last year.Cash and cash equivalents decreased significantly.

Summary

  • Astrotech Corporation reported a net loss of $4.009 million for the three months ended December 31, 2024, compared to a net loss of $2.641 million for the same period in 2023.
  • Revenue decreased to $261 thousand from $1.115 million year-over-year.
  • Research and development expenses increased to $2.437 million from $1.578 million year-over-year.
  • For the six months ended December 31, 2024, the net loss was $7.287 million compared to $5.553 million in 2023.
  • Revenue for the six-month period was $295 thousand, down from $1.540 million in the prior year.
  • The company's cash and cash equivalents decreased to $3.161 million as of December 31, 2024, from $10.442 million as of June 30, 2024.
  • The company entered into a new lease agreement for a facility of approximately 17,628 square feet in Austin, Texas, with total contractual base rent obligation of approximately $3.2 million.
  • The company's rights plan was extended to December 20, 2025.

Sentiment

Score: 4

Explanation: The document presents a mixed picture. While there are some positive developments like the DHS contract and increased gross margin, the significant decline in revenue and increase in net losses weigh heavily on the overall sentiment.

Positives

  • Gross margin increased to 59% for the three months ended December 31, 2024, compared to 48% for the same period in 2023.
  • 1st Detect received a research and development contract with the U.S. Department of Homeland Security (DHS).
  • 1st Detect received a purchase order for its TRACER 1000 explosive trace detectors (ETDs) from Intuitive Research and Technology Corporation a TSA contractor for $429 thousand.
  • The company's rights plan was extended to December 20, 2025.

Negatives

  • Revenue decreased significantly in both the three and six months ended December 31, 2024, compared to the same periods in 2023.
  • The company experienced increased net losses for both the three and six months ended December 31, 2024, compared to the same periods in 2023.
  • Cash and cash equivalents decreased significantly from June 30, 2024, to December 31, 2024.
  • The company had one customer that materially comprised all the Company's revenue for the three and six months ended December 31, 2024.

Risks

  • The company's manufacturing operations are dependent upon third-party suppliers, including single-source suppliers, making it vulnerable to external factors.
  • Changes in U.S. trade policy, including changes to existing trade agreements, may have a material adverse effect on the company.
  • The company is subject to risks and uncertainties related to the adverse impact of recent inflationary pressures, global economic conditions, and the COVID-19 pandemic.
  • The company faces product demand and market acceptance risks, including its ability to develop and sell products and services to be used by governmental or commercial customers.

Future Outlook

The company is focused on expanding access to mass spectrometry and its use through the deployment of devices designed for high-volume, real-time testing environments. They are commercializing the Astrotech Mass Spectrometer Technology platform through application-specific, wholly-owned subsidiaries.

Industry Context

The company operates in the mass spectrometry and security detection industries. The report mentions competition in the ETD market from IMS-based technologies and the growing hemp and cannabis market.

Comparison to Industry Standards

  • The document mentions that the TRACER 1000 is designed to outperform ETDs currently used at airports, cargo and other secured facilities, and borders worldwide, which are driven by ion mobility spectrometry (IMS).
  • The company believes that ETD customers are unsatisfied with the currently deployed ETD technology, which is driven by ion mobility spectrometry (IMS).
  • The AgLAB 1000-D2 is being developed for use in the hemp and cannabis markets with the initial focus on optimizing yields in the distillation process.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Chief Financial Officer, Treasurer and SecretaryJaime HinojosaRyan Polk (interim)February 14, 2025Resignation

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Rights Plan ExtensionThe company entered into Amendment No. 2 to the Rights Agreement, which extends the Final Expiration Date to December 20, 2025.December 12, 2024The rights plan is designed to protect the company from unwanted takeover attempts.

Legal Proceedings

  • The Company is not subject to any litigation at the present time.

Stakeholder Impact

  • Shareholders: The decreased revenue and increased net losses may negatively impact shareholder value.
  • Employees: Increased R&D spending could lead to new opportunities, but cost-cutting measures may also be implemented.
  • Customers: Continued development of new products and technologies could benefit customers.
  • Suppliers: The company's reliance on single-source suppliers poses a risk to the supply chain.

Next Steps

  • Continue field trials with the TSA for the TRACER 1000.
  • Continue sales efforts for the AgLAB 1000-D2.
  • Continue research and development efforts across its subsidiaries.
  • Exit the Donley facilities at the end of the initial term.
  • Support and encompass all Austin based functions during the initial term, beginning August 31, 2025.

Key Dates

DateDescription
1984Astrotech Corporation organized
April 27, 2021Astrotech entered into a new lease for a research and development facility in Austin, Texas
June 1, 2021Lease commenced for the research and development facility
March 31, 2021BreathTech entered into an Investigator-Initiated Study Agreement with The Cleveland Clinic Foundation
November 11, 2022Company signed a lease extension agreement for the R&D facility, extending the term of the lease through April 30, 2025
November 22, 2022Astrotech entered into a sublease agreement for an additional facility directly adjacent to the R&D facility
December 1, 2022Sublease commenced for the additional facility
December 21, 2022Company's Board of Directors adopted a limited duration stockholder rights plan
January 5, 2023Record date for dividend of one preferred share purchase right for each outstanding share of common stock
May 2023Successfully delivered a purchase order for 14 ETDs from a Romania-based company
December 12, 2023Announced the formation of new wholly owned subsidiary, Pro-Control
June 2024The TSA approved 1st Detects TRACER 1000 for the Air Cargo Security Technology List
June 13, 2024AgLAB and SC Laboratories (SC Labs) entered into a master lease agreement providing for the joint marketing of the AgLAB 1000-D2 mass spectrometer and the AgLAB Maximum Value Process testing method to SC Labs clients.
December 12, 2024Company entered into Amendment No. 2 to the Rights Agreement, which extends the Final Expiration Date to December 20, 2025
December 31, 2024End of the quarterly period
January 7, 2025Jaime Hinojosa informed the Company of his resignation from the positions of Chief Financial Officer, Treasurer and Secretary, effective February 14, 2025
January 14, 2025Company appointed Ryan Polk as interim Chief Financial Officer, Treasurer and Secretary of the Company, effective as of February 14, 2025
January 14, 20251st Detect Corporation, issued a press release announcing that it has been awarded research and development contract 70RSAT24CB0000015 with the U.S. Department of Homeland Security (DHS)
January 20, 2025Entered into an extension of the Donley facilities effective May 1, 2025 and terminating June 30, 2025 with an option to continue the lease on a month-to-month basis
January 23, 20251st Detect received a purchase order for its TRACER 1000 explosive trace detectors (ETDs) from Intuitive Research and Technology Corporation a TSA contractor
January 29, 2025Entered into a new lease agreement for a facility of approximately 17,628 square feet in Austin, Texas (the Metric facility)
February 7, 2025The CCF IISA terminated in accordance with its terms
February 14, 2025Date of report filing
April 30, 2025Expiration date of the CCF JDA
April 30, 2025Lease term ends for the R&D facility
May 1, 2025Extension of the Donley facilities effective
June 30, 2025Terminating date of the Donley facilities extension
August 31, 2025Beginning of the initial term for the Metric facility
December 20, 2025Extended Final Expiration Date of the Rights Plan

Keywords

Astrotech, mass spectrometry, TRACER 1000, 1st Detect, AgLAB, BreathTech, Pro-Control, explosives trace detection, revenue, net loss, research and development, financial results

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.